Safety of a novel gel formulation of clindamycin phosphate 1.2%-tretinoin 0.025%: Results from a 52-week open-label study

Leon H. Kircik, Marina I. Peredo, Alicia D. Bucko, Robert W. Loss, Joseph F. Fowler, Mitchell Wortzman, George J. Neumaier

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Safety of a novel gel formulation of clindamycin phosphate 1.2%-tretinoin 0.025%: Results from a 52-week open-label study'. Together they form a unique fingerprint.

Medicine & Life Sciences